Location: United States
The program uses a combination of nicotine replacement therapy and prescription medication for over 12 weeks to help people quit smoking. The initial doctor consultation is done online, and medication is shipped straight to the patient’s door.
According to the CDC, 13.7% of adults in the USA were smokers in 2018. Sixteen million Americans are living with a disease caused by smoking including cancer, COPD, diabetes, lung disease, heart disease, and more.
Nicotine is the highly addictive chemical in cigarettes that makes them so hard to quit, and why will power alone is often not enough. Using a combination of nicotine replacement therapy and bupropion, however, can increase the likelihood of success by more than three times.
Zero is making medicine-assisted treatment accessible online. The 12-week program includes an online consultation with a doctor where they can help the patient decide the best type of treatment for them. Based on that, a decision is made between using nicotine gum, bupropion, or a combination of both. After consulting with the doctor, the medication is sent straight to the patient’s door with free two-day shipping.
Patients are asked to begin treatment 1-2 weeks before their quit date if medication is part of their 12-week plan. Patients can reach out to their doctor with any questions through the online platform.
“Zero is part of a parent company called Ro. We recently featured Roman – Their telemedicine platform for men’s health. The interest and use in telemedicine has soared due to Covid-19 as healthcare embraces the virtual approach. It’s attracting lots of investment. This is clearly evident as Ro recently raised 200 million in a funding round valuing the company at $1.5 billion.” – Dr Vinay Shankar